Company Dossier · Consumer Staples
Procter & Gamble
- S&P 500
- S&P 100
- Dow 30
- Russell 1000
What Procter & Gamble is doing, read from its filings, its own words and the news, with every figure dated and sourced. Not investment advice: no ratings, no price targets.
Open the full company record in Palanor: guidance, KPIs, ownership, calls, prices →
The latest read
Computed from the data on Oct 22, 2026. Every figure links back to its source in the sections below.
- Revenue over the four quarters to June 30, 2026: $87.0 billion, up 3.3% from a year earlier.SEC EDGAR filings (XBRL)
- Free cash flow (operating cash flow minus capital expenditure) over the four quarters to June 30, 2026: $15.2 billion, up 7.9% from a year earlier.SEC EDGAR filings (XBRL)
- Capital expenditure over the four quarters to June 30, 2026: $4.41 billion, up 17% from a year earlier.SEC EDGAR filings (XBRL)
- Share buybacks in the fiscal year to June 30, 2026: $5.03 billion.SEC EDGAR filings (10-K)
- Long-term debt issued in the fiscal year to June 30, 2026: $2.65 billion.SEC EDGAR filings (10-K)
- Latest earnings call or results release (July 29, 2026): sentiment 0.20 on a −1 to +1 scale (mixed), confidence 0.40 of 1.Palanor Discourse
- Latest annual report (filed August 4, 2026): 0 risk factors added, 1 removed.Risk Factor Changes (10-K Item 1A)
- Insiders were net sellers in Q3 2026: $6.7 million on the open market.SEC Form 4
- 4,047 institutional managers reported a position at June 30, 2026 (+20 on the quarter before).SEC Form 13F
- H-1B filings certified in Q2 2026: 7 (13 a year earlier).U.S. Department of Labor (OFLC)
Company Posture
How Company Posture is measured →What Procter & Gamble is doing, on three axes, from its filings and its own words, as of 2026-10-22. A description, not a rating: Company Posture never says whether to buy.
Steady · Mixed
Expanding ↔ Retrenching
Steady
- Capital spending74th pct
- Debt raised—
- Buybacks vs capex49th pct
- Hiring filings61st pct
- Deals and private raises49th pct
- Patent publications19th pct
Confident ↔ Hedging
Mixed
- Call sentiment44th pct
- Call confidence8th pct
- Guidance changes58th pct
- Risk factors added64th pct
- Insider open-market trades40th pct
- − Call confidence
- + Risk factors added
- + Guidance changes
Pressure
Components only: Not yet shown as a score: in the back-test it did not add to a naive reader's forecast of impairment, debt acceleration or bankruptcy filings (8-K 2.06, 2.04, 1.03) (not enough events (17 in half 1; needs 20)).
- Fails-to-deliver34th pct
- Stress filings48th pct
Credit
How these are built →Procter & Gamble's borrowing from its SEC filings: the bonds it priced and the debt on its latest balance sheet. A description, not a rating.
Debt on the balance sheet
$34.1B
- Due within a year $11.3B
- Longer term $22.8B
- Default point $22.7B (short + ½ long)
Finance leases included · Jun 30, 2026 filing
Bonds priced, last 12 months
$1.3B
U.S. dollar tranches with a term sheet on EDGAR. Deals sold under Rule 144A file none and are not counted.
| Priced | Amount | Coupon | Matures | Spread | Yield |
|---|---|---|---|---|---|
| Oct 27, 2025 | $750M | 4.100% | 2032 (7y) | +32bp | 4.114% |
| Oct 27, 2025 | $500M | 4.350% | 2035 (10y) | +37bp | 4.371% |
| Apr 28, 2025 | $700M | 4.050% | 2030 (5y) | +28bp | 4.096% |
| Apr 28, 2025 | $550M | 4.600% | 2035 (10y) | +43bp | 4.644% |
| Oct 21, 2024 | $500M | 4.150% | 2029 (5y) | +22bp | 4.192% |
| Oct 21, 2024 | $500M | 4.550% | 2034 (10y) | +37bp | 4.550% |
| Jan 24, 2024 | $600M | 4.350% | 2029 (5y) | +27bp | 4.360% |
| Jan 24, 2024 | $750M | 4.550% | 2034 (10y) | +37bp | 4.550% |
From the pricing term sheets Procter & Gamble filed with the SEC. Spread is to the benchmark Treasury (or Bund, Gilt) at pricing.
Charts
Live charts: each one redraws from today’s data and has an image link to paste into a document or slide.
Cash flow
Capital returned and raised
What the company says
Hiring and ownership
In the news
Headlines that name Procter & Gamble, with the publisher and a link. The tone is read from each headline’s own words, never from a summary of the article.
- NeutralNotable analyst calls this week: Procter & Gamble, Palantir and SentinelOne among top picks
seekingalpha.com · via Marketaux · Oct 10, 2026
Filings and records
The last two years of notable 8-Ks, offerings, annual reports, federal awards, lobbying reports, patents and other public records, newest first.
- Oct 21, 2026LobbyingLobbying report (HARBINGER STRATEGIES, LLC)third_quarter 2026 · $0.1 million
- Oct 20, 2026LobbyingLobbying report (RIDGELINE ADVOCACY GROUP LLC)third_quarter 2026
- Oct 20, 2026LobbyingLobbying report (BGR GOVERNMENT AFFAIRS)third_quarter 2026 · $0.1 million
- Oct 20, 2026PatentPatent granted: SHAVING RAZOR SYSTEMUS 12766750
- Oct 20, 2026Patent
- Oct 16, 20268-KShareholder vote resultsItem 5.07
- Oct 15, 2026LobbyingLobbying report (THE WASHINGTON TAX & PUBLIC POLICY GROUP)third_quarter 2026 · $0.0 million
- Oct 14, 2026Trademark
- Oct 13, 2026Patent
- Oct 13, 2026Patent
- Sep 29, 2026Patent
- Sep 17, 2026Trademark
- Sep 4, 2026Trademark
- Aug 26, 2026Trademark
- Aug 4, 202610-KAnnual report (10-K)0 risk factors added, 1 removed
- Aug 4, 2026Trademark
- Jul 29, 20268-KDirector or officer changeItem 5.02
- Jul 22, 2026LobbyingLobbying report (THE PROCTER AND GAMBLE COMPANY)second_quarter 2026 · $0.7 million
- Jul 21, 2026LobbyingLobbying report (HARBINGER STRATEGIES, LLC)second_quarter 2026 · $0.1 million
- Jul 21, 2026LobbyingLobbying report (RIDGELINE ADVOCACY GROUP LLC)second_quarter 2026 · $0.1 million
- Jul 20, 2026LobbyingLobbying report (BGR GOVERNMENT AFFAIRS)second_quarter 2026 · $0.1 million
- Dec 15, 20258-KDirector or officer changeItem 5.02
- Oct 16, 20258-KDirector or officer changeItem 5.02
- Oct 16, 20258-KShareholder vote resultsItem 5.07
- Aug 14, 20258-KDirector or officer changeItem 5.02
- Aug 4, 202510-KAnnual report (10-K)0 risk factors added, 0 removed
- Jul 28, 20258-KDirector or officer changeItem 5.02
- Jun 20, 2025Risk event
- Jun 9, 20258-KDirector or officer changeItem 5.02
- Aug 5, 202410-KAnnual report (10-K)0 risk factors added, 1 removed
Peers
Companies in the same industry in the S&P 500, Russell 1000 or MidCap 400, closest in revenue first. Trailing twelve months, from SEC filings.
| Company | Revenue | Free cash flow | Through |
|---|---|---|---|
| Colgate-Palmolive CL | $21.1B | $3.9B | Jun 30, 2026 |
| Kimberly-Clark KMB | $16.6B | $1.8B | Jun 30, 2026 |
| Clorox CLX | $6.8B | $0.4B | Mar 31, 2026 |
| Church & Dwight CHD | $6.2B | — | Jun 30, 2026 |
| Sysco SYY | $84.5B | $1.9B | Jun 27, 2026 |
| Performance Food Group PFGC | $67.8B | $1.0B | Jun 27, 2026 |
| Tyson Foods TSN | $55.7B | $1.2B | Jun 27, 2026 |
| Coca-Cola Co. KO | $49.3B | $12.6B | Apr 3, 2026 |